scholarly journals Editorial

Author(s):  
Dr. Gurinder Singh Rajput

I am pleased to present the Volume 2 Issue 1 of Asian Journal of Chemistry and Pharmaceutical Sciences. AJCPS is a quarterly peer-reviewed journal committed to publish the high quality articles in all area of chemistry and pharmaceutical science. Chemistry and Pharmaceutical science are closely related disciplines and their convergence is very frequent. In spite of excessive ongoing research in these disciplines very few journals, especially from Asian region are available those cover both the subjects. I hope that AJCPS will encourage the researchers, students and academicians involved in Chemistry and Pharmaceutical research.

2018 ◽  
Vol 161 ◽  
pp. 03016 ◽  
Author(s):  
Ilya Mavrin ◽  
Roman Lavrenov ◽  
Mikhail Svinin ◽  
Sergey Sorokin ◽  
Evgeni Magid

Recently a large variety of robots are available on the global market for a reasonable price. Often it turns out that even though a robot has a high-quality hardware and architecture, an original software of the robot may have a number of drawbacks or lacks some important features, which are required for a particular application of the robot. In such cases a user may decide to implement new libraries and functionalities using a provided by a manufacturer application programming interfaces as in most cases code of a commercial robot system is not an open-source. A number of our ongoing research projects concentrate on applications of various robots in urban search and rescue operations, and in most of these projects utilize Russian crawler robot Servosila Engineer. This paper describes the development of a new ROS-based control software and graphical user interface for Servosila Engineer robot.


2009 ◽  
Vol 11 (4) ◽  
pp. 108
Author(s):  
Brian C. Foster

Foresight Scanning: Future Directions of Clinical and Pharmaceutical Research. Brian C. Foster, Therapeutic Products Directorate, Health Canada, Ottawa, Ontario, Canada ABSTRACT The Canadian Society for Pharmaceutical Sciences Satellite Symposium on Foresight Scanning, May 26 and 27, 2008, Nordegg, Alberta, Canada, focussed on the future directions of clinical and pharmaceutical research. The symposium brought together a group of clinicians, regulatory scientists, researchers and students to examine where clinical, pharmaceutical, and regulatory science might be in 10 to 15 years. Industry, regulatory, analytical, and clinical perspectives were presented and discussed, as well as the impact of exogenous (indirect) and endogenous (direct) change drivers. Unconditional funding was provided by Bayer HealthCare; they had no input on the direction of the meeting or selection of speakers. It was envisioned that the more important endogenous drivers may not be new information or changes in technology, policy, regulation, or health care delivery, but amplification of long-term underlying trends by emergence of new technologies, convergence of existing technologies or new communication and collaboration vehicles such as Web 2.0.


BMJ Open ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. e034960
Author(s):  
Gavin Wooldridge ◽  
Srinivas Murthy ◽  
Niranjan Kissoon

IntroductionSepsis is the leading cause of death in children worldwide and has recently been declared a major global health issue. New interventions and a concerted effort to enhance our understanding of sepsis are required to address the huge burden of disease, especially in low- and middle-income countries (LMIC) where it is highest. An opportunity therefore exists to ensure that ongoing research in this area is relevant to all stakeholders and is of consistently high quality. One method to address these issues is through the development of a core outcome set (COS).Methods and analysisThis study protocol outlines the phases in the development of a core outcome set for paediatric sepsis in LMIC. The first step involves performing a systematic review of all outcomes reported in the research of paediatric sepsis in low middle-income countries. A three-stage international Delphi process will then invite a broad range of participants to score each generated outcome for inclusion into the COS. This will include an initial two-step online survey and finally, a face-to-face consensus meeting where each outcome will be reviewed, voted on and ratified for inclusion into the COS.Ethics and disseminationNo core outcome sets exist for clinical trials in paediatric sepsis. This COS will serve to not only highlight the heavy burden of paediatric sepsis in this setting and aid collaboration and participation between all stakeholders, but to promote ongoing essential high quality and relevant research into the topic. A COS in paediatric sepsis in LMIC will advocate for a common language and facilitate interpretation of findings from a variety of settings. A waiver for ethics approval has been granted by University of British Columbia Children’s and Women’s Research Ethics Board.


2008 ◽  
Vol 13 (5) ◽  
pp. 413-420 ◽  
Author(s):  
Janet Yamada ◽  
Jennifer Stinson ◽  
Jasmine Lamba ◽  
Alison Dickson ◽  
Patrick J McGrath ◽  
...  

BACKGROUND: Hospitalized infants undergo multiple, repeated painful procedures. Despite continued efforts to prevent procedural pain and improve pain management, clinical guidelines and standards frequently do not reflect the highest quality evidence from systematic reviews.OBJECTIVE: To critically appraise all systematic reviews on the effectiveness of procedural pain interventions in hospitalized infants.METHODS: A structured review was conducted on published systematic reviews and meta-analyses of pharmacological and nonpharmacological interventions of acute procedural pain in hospitalized infants. Searches were completed in the Cochrane Database of Systematic Reviews, MEDLINE, EMBASE, CINAHL and PsycINFO. Two reviewers independently selected articles for review and rated the methodological quality of the included reviews using a validated seven-point quality assessment measure. Any discrepancies were resolved by a third reviewer.RESULTS: Of 1469 potential systematic reviews on interventions for painful procedures in hospitalized infants, 11 high-quality reviews were included in the analysis. Pharmacological interventions supported by research evidence included premedication for intubation, dorsal penile nerve block and EMLA (AstraZeneca Canada, Inc) for circumcision, and sucrose for single painful procedures. Non-nutritive sucking, swaddling, holding, touching, positioning, facilitative tucking, breast feeding and supplemental breast milk were nonpharmacological interventions supported for procedural pain.CONCLUSION: There is a growing number of high-quality reviews supporting procedural pain management in infants. Ongoing research of single, repeated and combined pharmacological and nonpharmacological interventions is required to provide the highest quality evidence to clinicians for decision-making on optimal pain management.


Author(s):  
Sourour Idoudi ◽  
Mohamed Izham Mohamed Ibrahim ◽  
Feras Alali ◽  
Nashiru Billa

Backgrround: Pharmaceutical science is an important area in drug discovery and therapies.The research output generated from pharmaceutical sciences research is critical for psychological, physical, and social wellbeing. This study was carried out to analyze Qatar's quantity and quality of pharmaceutical sciences-related research and map out a national research roadmap and priority areas. Materials and Methods: A systematic search was carried out in the Web of Science, Scopus, Pub Med, and Google Scholar databases using the search terms “Pharmaceutical Science,” “Pharmaceutical Chemistry,” “Medicinal Chemistry,” “Pharmacology,” “Pharmaceutics,” “Pharmacokinetics,” “Physiology,” “Pharmaceutical Science research,” “Study,” other relevant terms related to Pharmaceutical Sciences field and “Qatar.”The search covered eight years. The data extracted included the title, keywords, publication date, authors, publishing journal, journal ranking, impact factor, type of article, number of citations, the sum of citations, H-index, etc. Results: The search yielded123 studies. Most were original articles (n=100, 81.3%), published in 2019 (n=27, 22.0%), applied research (n=68, 55.3%),indexed in Web of Science (n=120, 97.6%),published under the subject of pharmacology (n=43, 42.6%), focused on cancer (n=46, 37.4%)and produced by five authors (n=19, 18.8%) and more than eight authors (n=19, 18.8%). Hamad Medical Corporation (HMC) was the main collaborator (n=16, 13.0%). Fifty-four (43.9%) of the articles were published in journals ranked as Q1. Conclusions: A total of 123 articles were published, with an average annual growth rate of 6.7% in publications and 946 citations. A high number of publications were in Q1 and Q2 journals. The research focus (e.g., cancer and cardiovascular) was established according to the country’s research roadmap and priority areas.


2016 ◽  
Author(s):  
Benjamin J. Tully ◽  
Rohan Sachdeva ◽  
Elaina D. Graham ◽  
John F. Heidelberg

AbstractThe Tara Oceans Expedition has provided large, publicly-accessible microbial metagenomic datasets from a circumnavigation of the globe. Utilizing several size fractions from the samples originating in the Mediterranean Sea, we have used current assembly and binning techniques to reconstruct 290 putative high-quality metagenome-assembled bacterial and archaeal genomes, with an estimated completion of ≥50%, and an additional 2,786 bins, with estimated completion of 0-50%. We have submitted our results, including initial taxonomic and phylogenetic assignments, for the putative high-quality genomes to open-access repositories for the scientific community to use in ongoing research.


2016 ◽  
Vol 19 (3) ◽  
pp. 1
Author(s):  
Beverley Berekoff

Plenaries and Special Presentations:Carolyn Buser-Doepner, GSK:  "New Trends in Pharma-Academia Collaborations for Drug Discovery"Chris Halyk, President, Janssen Inc.:  "Are Innovative Medicines and our Life Sciences Industry at Risk in Canada?"Aaron Schimmer, Princess Margaret Cancer Centre:  "New Therapeutic Strategies to Target the Mitochondria in Leukemia"Ivana Cecic, Genome BC:  "Genomics in Canada: From Knowledge Generation to Patient Outcomes"Adam Rosebrock, University of Toronto:  "Quantitative Mass-Spectrometry Metabolomics for Direct Biochemical Phenotyping"Fakhreddin Jamali, University of Alberta: CSPS Lifetime Achievement Award Lecture - "Pharmaceutical Research and Development, Lessons Learned"Conference Sessions:Special Session: Innovation and Management of Modern Pharmaceuticals1. Special Populations2. Nanomedicines Become Personal: Opportunities and Challenges3. Mucosal Drug Delivery4. Broaching the Fourth Hurdle: Getting Drugs on the Formulary5. Pharmacogenomics in the Clinic and Community6. Responsive Drug Delivery Systems7. Drug Targeting and Targeting Drugs8. Health Sustainability Evidence9. Integrating Pharmaceutical Sciences into a Pharm D Curriculum10. Analytical Innovation to Support Precision Medicine and Biologicals Development11. Protein and Peptide Delivery


2011 ◽  
Vol 26 (1) ◽  
pp. 19-28 ◽  
Author(s):  
Carlos Antonio Costa dos Santos

The main objective of this study was to obtain analysis of the trends in eleven annual extreme indices of temperature for Utah, United State of America (USA). The analyses have been obtained for 28 meteorological stations, in general, for the period of 1930 to 2006, characterizing a long-term period and with high quality data. The software used to process the data was the RClimdex 1.0. The analysis has identified that the temperature increased in Utah during the last century, evidencing the importance of the ongoing research on climate change in many parts of the world.


2021 ◽  
Vol 99 (4) ◽  
Author(s):  
Emily J Arentson-Lantz ◽  
Sean Kilroe

Abstract Like humans, many companion animals experience a gradual decline in skeletal muscle mass and function during later years of life. This process, analogous to sarcopenia in humans, increases risk for morbidity and mortality. Periods of reduced activity due to injury or illness, followed by an incomplete recovery, can accelerate the loss of muscle mass and function. Emerging research from human studies suggests that moderate amounts of high-quality protein may attenuate the loss of muscle, while preventing accumulation of fat during periods of disuse. Whey protein is a consumer-friendly and readily available source of high-quality protein. It supports skeletal muscle maintenance during normal aging and may also provide anabolic support during periods of illness, injury, and recovery. Ongoing research efforts continue to refine our understanding of how protein quality, quantity, and meal timing can be optimized to support retention of muscle mass and function during aging. Priority research areas include supplementation with high-quality protein during illness/injury to stimulate anabolism by targeting molecular mechanisms that regulate skeletal muscle metabolism.


Sign in / Sign up

Export Citation Format

Share Document